Med BioGene Inc (MBIh)

TSXV
0.1050
0.0000(0.00%)
  • Volume:
    0
  • Bid/Ask:
    0.1050/0.1900
  • Day's Range:
    0.1050 - 0.1050
  • Type:Equity
  • Market:Canada
  • ISIN:CA58402B3056
  • CUSIP:58402B305

MBIh Overview

Prev. Close
0.12
Day's Range
0.105-0.105
Revenue
-
Open
0.105
52 wk Range
0.05-0.23
EPS
0
Volume
0
Market Cap
1.6M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
5,647
P/E Ratio
-
Beta
-0.04
1-Year Change
110%
Shares Outstanding
15,257,838
Next Earnings Date
-
What is your sentiment on Med BioGene Inc?
or
Market is currently closed. Voting is open during market hours.

Med BioGene Inc News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellSell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellNeutral
SummaryStrong SellStrong SellStrong SellStrong SellNeutral

Med BioGene Inc Company Profile

Med BioGene Inc Company Profile

Employees
0
Market
Canada

Med BioGene Inc. (MBI) is a Canada-based development-stage life science company. The Company is focused on the development and commercialization of genomic-based clinical laboratory diagnostic tests for cancer. The Company is also focused on managing the license and rights to GeneFx Lung. Its test under development, which is GeneFx Lung (formerly known as LungExpress Dx) is a gene expression-based test to improve upon staging for identifying those patients with early-stage non-small-cell lung cancer (NSCLC).

Read More
  • is this going to go up?
    0
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.